200 related articles for article (PubMed ID: 22021213)
1. Substructure-based virtual screening for adenosine A2A receptor ligands.
van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
[TBL] [Abstract][Full Text] [Related]
2. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
3. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective adenosine A(2A) receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones.
Harris JM; Neustadt BR; Zhang H; Lachowicz J; Cohen-Williams M; Varty G; Hao J; Stamford AW
Bioorg Med Chem Lett; 2011 Apr; 21(8):2497-501. PubMed ID: 21398125
[TBL] [Abstract][Full Text] [Related]
5. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
6. The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.
Jaakola VP; Ijzerman AP
Curr Opin Struct Biol; 2010 Aug; 20(4):401-14. PubMed ID: 20538452
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
[TBL] [Abstract][Full Text] [Related]
8. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel and Selective Adenosine A
Tian S; Wang X; Li L; Zhang X; Li Y; Zhu F; Hou T; Zhen X
J Chem Inf Model; 2017 Jun; 57(6):1474-1487. PubMed ID: 28463561
[TBL] [Abstract][Full Text] [Related]
10. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel adenosine A(2A) receptor antagonists by virtual screening.
Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M
J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.
Schneider G; Nettekoven M
J Comb Chem; 2003; 5(3):233-7. PubMed ID: 12739938
[TBL] [Abstract][Full Text] [Related]
13. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
14. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
El-Tayeb A; Gollos S
Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
[TBL] [Abstract][Full Text] [Related]
16. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR studies of analogues of 4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-N-thiazol-2-yl-benzamide (Lu AA41063) as adenosine A2A receptor ligands with improved aqueous solubility.
Mikkelsen GK; Langgård M; Schrøder TJ; Kreilgaard M; Jørgensen EB; Brandt G; Griffon Y; Boffey R; Bang-Andersen B
Bioorg Med Chem Lett; 2015 Mar; 25(6):1212-6. PubMed ID: 25701253
[TBL] [Abstract][Full Text] [Related]
18. In search of novel ligands using a structure-based approach: a case study on the adenosine A
Lenselink EB; Beuming T; van Veen C; Massink A; Sherman W; van Vlijmen HW; IJzerman AP
J Comput Aided Mol Des; 2016 Oct; 30(10):863-874. PubMed ID: 27629350
[TBL] [Abstract][Full Text] [Related]
19. Water network perturbation in ligand binding: adenosine A(2A) antagonists as a case study.
Bortolato A; Tehan BG; Bodnarchuk MS; Essex JW; Mason JS
J Chem Inf Model; 2013 Jul; 53(7):1700-13. PubMed ID: 23725291
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
